Clinical Trial: A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease

U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07555054) titled 'A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease' on April 21.

Brief Summary: The purpose of the study was to evaluate the efficacy and safety of HS-10390 in participants with chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) >= 30 and = 150 mg/g and < 3000 mg/g

Study Start Date: May 21

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease

Intervention: DRUG: HS-10390

HS-10390

DRUG: HS-10390

HS-10390

DRUG: HS-10390

HS-10390

DRUG: Irbesartan

Target dose of 300 mg daily

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu Han...